Wikidata

(Q65386201)

English

Study Of SB-683699 Compared To Placebo In Subjects With Relapsing-Remitting Multiple Sclerosis (MS)

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

title
Randomised, Double-blind, Placebo-controlled, Parallel-group, Dose-ranging Study to Investigate the MRI Efficacy and the Safety of Six Months Administration of SB-683699 in Subjects With Relapsing-Remitting Multiple Sclerosis (English)
0 references
medical condition
sclerosis
0 references
multiple sclerosis
0 references
sponsor
GSK
0 references
country
Australia
0 references
Austria
0 references
Canada
0 references
Finland
0 references
France
0 references
Germany
0 references
Italy
0 references
Netherlands
0 references
New Zealand
0 references
Norway
0 references
Poland
0 references
Spain
0 references
United Kingdom
0 references
start time
December 2006
0 references
end time
August 2009
0 references
number of participants
343
0 references
research site
GSK
0 references
minimum age
18 year
0 references
maximum age
65 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q65386201&oldid=2237533209"